site stats

Mahendran botlagunta oncogene ddx3

Webscientific article published on 11 February 2008 WebMin Xie, Farhad Vesuna, Mahendran Botlagunta, Guus Martinus Bol, Ashley Irving, Yehudit Bergman, Ramachandra S. Hosmane, Yoshinori Kato, Paul T. Winnard, Venu …

Oncogenic role of DDX3 in breast cancer biogenesis - PubMed

WebOncogenic role of DDX3 in breast cancer biogenesis. Botlagunta M; Vesuna F; Mironchik Y; et al. See more; Oncogene (2008) 27(28) 3912-3922. DOI: 10.1038/onc.2008.33. 148 … WebDDX3 has a variety of functions in the life cycle of di erent viruses. DDX3 helicase is required to facilitate both the Rev-mediated export of unspliced/partially spliced human … 07世代 https://pferde-erholungszentrum.com

Mahendran Botlagunta KLUNIVERSITY - Academia.edu

WebIt suggests that DDX3 can be used as a biomark-er for the diagnosis of colorectal cancer patient samples.[9] DDX3 was found to be expressed in both pediatric (55%) and adult … WebDEAD box protein, DDX3, is aberrantly expressed in breast cancer cells ranging from weakly invasive to aggressive phenotypes and functions as an important regulator of cancer cell growth and survival. Here, we demonstrate that hypoxia inducible factor-1a is a transcriptional activator of DDX3 in breast cancer cells. Web1 jul. 2008 · Oncogenic role of DDX3 in breast cancer biogenesis Authors: Mahendran Botlagunta Basavatarakam Indo American Cancer Hospital & Research Institute Farhad … 07二进制

Oncogenic role of DDX3 in breast cancer biogenesis

Category:dr. G.M. (Guus) Bol - UMC Utrecht

Tags:Mahendran botlagunta oncogene ddx3

Mahendran botlagunta oncogene ddx3

Expression of DDX3 Is Directly Modulated by Hypoxia Inducible …

Web26 jun. 2008 · It is concluded that DDX3 has an oncogenic role in colorectal cancer and inhibition ofDDX3 with the small molecule inhibitor RK-33 causes inhibition of Wnt … Web11 jan. 2015 · by Mahendran Botlagunta Cancer is a one of the leading causes of death worldwide. A number of chemotherapeutic agents have been used for chemoprevention and they often have shown to contribute to chemotherapy-related cancer fatigue (CRF) caused by malabsorption... more Publisher: Elsevier Publication Date: 2016 Publication Name: …

Mahendran botlagunta oncogene ddx3

Did you know?

Web16 mei 2013 · Aims DDX3 is an RNA helicase that has antiapoptotic properties, and promotes proliferation and transformation. In addition, DDX3 was shown to be a direct downstream target of HIF-1α (the master … WebExpression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells Mahendran Botlagunta1, Balaji Krishnamachary1, Farhad Vesuna1, Paul …

Web2 dec. 2013 · Research Output (19) DDX3, a potential target for cancer treatment. Bol Guus Martinus, Xie Min, Raman Venu 5 Nov 2015, In: Molecular Cancer. 14. NZ51, a ring … Web3 Mahendran Botlagunta, Bhulakshmi Kollapalli, Lavanya Kakarla, Siva Priya Gajarla, Sai Pujitha Gade, Chandra Lekha Dadi, Akhila Penumadu and Shaik Javeed In vitro anti …

Web• Mahendran Botlagunta, Method for Preparing a Polyherbal Nano-Paste ( Indian Patent Application Number: 3568/CHE/2013) Grant Support • “Targeted delivery of Nano … Web1 jan. 2008 · Mahendran Botlagunta Download Free PDF View PDF MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, …

WebMahendran Botlagunta [...] Smita C Pawar The DEAD-box helicase family member DDX3 is involved in many diseases, such as viral infection, inflammation, and cancer. Many …

Web25 jan. 2024 · DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. by Omprakash Shriwas, Manashi … 07云Web28 apr. 2015 · DDX3 belongs to DEAD box RNA helicase family and is involved in the progression of several types of cancer. In this work, we employed a High Throughput … 07五粮液价格WebMahendran Botlagunta 2011, PLOS One DEAD box protein, DDX3, is aberrantly expressed in breast cancer cells ranging from weakly invasive to aggressive phenotypes … 07代码研究生